Lactobacillus plantarum B7 attenuates Salmonella typhimurium infection in mice: preclinical study in vitro and in vivo

[1]McClelland M, Wilson RK. Comparison of sample sequences of the Salmonella typhi genome to the sequence of the complete Escherichia coli K-12 genome. Infect Immun. 1998; 66:4305–12.McClellandMWilsonRKComparison of sample sequences of the Salmonella typhi genome to the sequence of the complete Escherichia coli K-12 genomeInfect Immun19986643051210.1128/IAI.66.9.4305-4312.19981085209712782Search in Google Scholar

[2]Hapfelmeier S, Hardt WD. A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol. 2005; 13:497–503.HapfelmeierSHardtWDA mouse model for Styphimurium-induced enterocolitis. Trends Microbiol20051349750310.1016/j.tim.2005.08.00816140013Search in Google Scholar

[3]Coburn B, Grassl GA, Finlay BB. Salmonella the host and disease: a brief review. Immunol Cell Biol. 2007; 85:112–8.CoburnBGrasslGAFinlayBBSalmonella the host and disease: a brief reviewImmunol Cell Biol200785112810.1038/sj.icb.710000717146467Search in Google Scholar

[4]Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011; 45(Suppl):S149–53.GuandaliniSProbiotics for prevention and treatment of diarrheaJ Clin Gastroenterol201145SupplS1495310.1097/MCG.0b013e3182257e9821992955Search in Google Scholar

[5]Williams NT. Probiotics. Am J Health Syst Pharm. 2010; 67:449–58.WilliamsNTProbioticsAm J Health Syst Pharm2010674495810.2146/ajhp09016820208051Search in Google Scholar

[6]de Vrese M, Marteau PR. Probiotics and prebiotics: effects on diarrhea. J Nutr. 2007; 137(Suppl 3):S803–11.deVrese MMarteauPRProbiotics and prebiotics: effects on diarrheaJ Nutr2007137Suppl 3S8031110.1093/jn/137.3.803S17311979Search in Google Scholar

[7]Yan F, Polk, DB. Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastroenterol. 2004; 20:565–71.YanFPolkDBCommensal bacteria in the gut: learning who our friends areCurr Opin Gastroenterol2004205657110.1097/00001574-200411000-0001115703684Search in Google Scholar

[8]Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2001; 13:1143–7.NiedzielinKKordeckiHBirkenfeldBA controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndromeEur J Gastroenterol Hepatol2001131143710.1097/00042737-200110000-0000411711768Search in Google Scholar

[9]Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med. 2005; 257:78–92.SullivanANordCEProbiotics and gastrointestinal diseasesJ Intern Med2005257789210.1111/j.1365-2796.2004.01410.x15606379Search in Google Scholar

[10]Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea. Curr Opin Clin Nutr Metab Care. 2006; 9:717–21.YanFPolkDBProbiotics as functional food in the treatment of diarrheaCurr Opin Clin Nutr Metab Care200697172110.1097/01.mco.0000247477.02650.5117053425Search in Google Scholar

[11]Teanpaisan R, Piwat S, Dahlén G. Inhibitory effect of oral Lactobacillus against oral pathogens. Lett Appl Microbiol. 2011; 53:452–9.TeanpaisanRPiwatSDahlénGInhibitory effect of oral Lactobacillus against oral pathogensLett Appl Microbiol201153452910.1111/j.1472-765X.2011.03132.xSearch in Google Scholar

[12]Dhanani AS, Bagchi T. Lactobacillus plantarum CS24.2 prevents Escherichia coli adhesion to HT-29 cells and also down-regulates enteropathogen-induced tumor necrosis factor-a and interleukin-8 expression. Microbiol Immunol. 2013; 57:309–15.DhananiASBagchiTLactobacillus plantarum CS24.2 prevents Escherichia coli adhesion to HT-29 cells and also down-regulates enteropathogen-induced tumor necrosis factor-a and interleukin-8 expressionMicrobiol Immunol2013573091510.1111/1348-0421.12038Search in Google Scholar

[13]Duary RK, Bhausaheb MA, Batish VK, Grover S. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep. 2012; 39:4765–75.DuaryRKBhausahebMABatishVKGroverSAnti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse modelMol Biol Rep20123947657510.1007/s11033-011-1269-1Search in Google Scholar

[14]Noguchi S, Hattori M, Sugiyama H, Hanaoka A, Okada S, Yoshida T. Lactobacillus plantarum NRIC1832 enhances IL-10 production from CD4⁺ T cells in vitro Biosci Biotechnol Biochem. 2012; 76:1925–31.NoguchiSHattoriMSugiyamaHHanaokaAOkadaSYoshidaTLactobacillus plantarum NRIC1832 enhances IL-10 production from CD4⁺ T cells in vitroBiosci Biotechnol Biochem20127619253110.1271/bbb.120404Search in Google Scholar

[15]Anderson RC, Cookson AL, McNabb WC, Kelly WJ, Roy NC. Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett. 2010; 309:184–92.AndersonRCCooksonALMcNabbWCKellyWJRoyNCLactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier functionFEMS Microbiol Lett. 20103091849210.1111/j.1574-6968.2010.02038.xSearch in Google Scholar

[16]Frias J, Song YS, Martinez-Villaluenga C, González de Mejia E, Vidal-Valverde C. Immunoreactivity and amino acid content of fermented soybean products. J Agric Food Chem. 2008; 56:99–105.FriasJSongYSMartinez-VillaluengaCGonzálezde Mejia EVidal-ValverdeCImmunoreactivity and amino acid content of fermented soybean productsJ Agric Food Chem2008569910510.1021/jf072177jSearch in Google Scholar

[17]Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008; 14:166–71.SpinlerJKTaweechotipatrMRognerudCLOuCNTumwasornSVersalovicJHuman-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogensAnaerobe2008141667110.1016/j.anaerobe.2008.02.001Search in Google Scholar

[18]Panpetch W. Detection of Lactobacillus in the stomach of dyspeptic patients and its role in the suppression of TNF production in vitro [MSc Thesis]. Bangkok, Thailand: Chulalongkorn Univ., 2008.PanpetchWDetection of Lactobacillus in the stomach of dyspeptic patients and its role in the suppression of TNF production in vitro [MSc Thesis]Bangkok, ThailandChulalongkorn Univ2008Search in Google Scholar

[19]Barthe M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003; 71:2839–58.BartheMHapfelmeierSQuintanilla-MartínezLKremerMRohdeMHogardtMet alPretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and hostInfect Immun20037128395810.1128/IAI.71.5.2839-2858.2003Search in Google Scholar

[20]Bouraoui M, Richard P, Fichtali J. A review of moisture content determination in foods using microwave oven drying. Food Research International. 1993; 26:49–51.BouraouiMRichardPFichtaliJA review of moisture content determination in foods using microwave oven dryingFood Research International199326495110.1016/0963-9969(93)90105-RSearch in Google Scholar

[21]Nishimuta M, Inoue N, Kodama N, Moriknni E, Yoshioka YH, Matsuzaki N, et al. Moisture and mineral content of human feces–high fecal moisture is associated with increased sodium and decreased potassium content. J Nutr Sci Vitaminol. 2006; 52:121–6.NishimutaMInoueNKodamaNMoriknniEYoshiokaYHMatsuzakiNet alMoisture and mineral content of human feces–high fecal moisture is associated with increased sodium and decreased potassium contentJ Nutr Sci Vitaminol200652121610.3177/jnsv.52.12116802692Search in Google Scholar

[22]Bohnhoff M, Drake BL, Miller CP. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med. 1954; 86:132–7.BohnhoffMDrakeBLMillerCPEffect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infectionProc Soc Exp Biol Med195486132710.3181/00379727-86-2103013177610Search in Google Scholar

[23]Abdel-Daim A, Hassouna N, Hafez M, Ashor MS, Aboulwafa MM. Antagonistic activity of Lactobacillus isolates against Salmonella typhi in vitro Biomed Res Int. 2013; 2013:680605. 10.1155/2013/680605Abdel-DaimAHassounaNHafezMAshorMSAboulwafaMMAntagonistic activity of Lactobacillus isolates against Salmonella typhi in vitroBiomed Res Int2013201368060510.1155/2013/680605380435824191248Open DOISearch in Google Scholar

[24]Chiu HH, Tsai CC, Hsih HY, Tsen HY. Screening from pickled vegetables the potential probiotic strains of lactic acid bacteria able to inhibit the Salmonella invasion in mice. J Appl Microbiol. 2008; 104:605–12.ChiuHHTsaiCCHsihHYTsenHYScreening from pickled vegetables the potential probiotic strains of lactic acid bacteria able to inhibit the Salmonella invasion in miceJ Appl Microbiol20081046051210.1111/j.1365-2672.2007.03573.x17927755Search in Google Scholar

[25]Das JK, Mishra D, Ray P, Tripathy P, Beuria TK, Singh N, Suar M. In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis. Gut Pathog. 2013; 5:11. 10.1186/1757-4749-5-11DasJKMishraDRayPTripathyPBeuriaTKSinghNSuarMIn vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar EnteritidisGut Pathog201351110.1186/1757-4749-5-11366260223668384Open DOISearch in Google Scholar

[26]Zhu X, Zhao Y, Sun Y, Gu Q. Purification and characterisation of plantaricin ZJ008, a novel bacteriocin against Staphylococcus spp. from Lactobacillus plantarum ZJ008. Food Chem. 2014; 165:216–23.ZhuXZhaoYSunYGuQPurification and characterisation of plantaricin ZJ008, a novel bacteriocin against Staphylococcus sppfrom Lactobacillus plantarum ZJ008. Food Chem20141652162310.1016/j.foodchem.2014.05.03425038669Search in Google Scholar

[27]Hasslöf P, Hedberg M, Twetman S, Stecksén-Blicks C. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study. BMC Oral Health. 2010; 10:18. 10.1186/1472-6831-10-18HasslöfPHedbergMTwetmanSStecksén-BlicksCGrowth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro studyBMC Oral Health2010101810.1186/1472-6831-10-18290855520598145Open DOISearch in Google Scholar

[28]Shahlaa MS, Zahraa KZ. Protective effect of Lactobacillus plantarum against Salmonella typhimurium in mice. J Fac Med Baghdad. 2010; 52:475–9.ShahlaaMSZahraaKZProtective effect of Lactobacillus plantarum against Salmonella typhimurium in miceJ Fac Med Baghdad2010524759Search in Google Scholar

[29]Ishikawa H, Kutsukake E, Fukui T, Sato I, Shirai T, Kurihara T, et al. Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica serovar Typhimurium. Biosci Biotechnol Biochem. 2010; 74:1338–42.IshikawaHKutsukakeEFukuiTSatoIShiraiTKuriharaTet alOral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica serovar TyphimuriumBiosci Biotechnol Biochem20107413384210.1271/bbb.9087120622449Search in Google Scholar

[30]Sunanliganon C, Thong-Ngam D, Tumwasorn S, Klaikeaw N. Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation. World J Gastroenterol. 2012; 18:2472–80.SunanliganonCThong-NgamDTumwasornSKlaikeawNLactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammationWorld J Gastroenterol20121824728010.3748/wjg.v18.i20.2472336044522654444Search in Google Scholar

[31]O’Toole PW, Cooney JC. Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis. 2008; 2008:175285. 10.1155/2008/175285O’ToolePWCooneyJCProbiotic bacteria influence the composition and function of the intestinal microbiotaInterdiscip Perspect Infect Dis2008200817528510.1155/2008/175285264862219277099Open DOISearch in Google Scholar

[32]Bäuerl C, Llopis M, Antolín M, Monedero V, Mata M, Zúñiga M, et al. Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa. Genes Nutr. 2013; 8:165–80.BäuerlCLlopisMAntolínMMonederoVMataMZúñigaMet alLactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosaGenes Nutr201381658010.1007/s12263-012-0301-y357588522669626Search in Google Scholar

[33]Borthakur A, Anbazhagan AN, Kumar A, Raheja G, Singh V, Ramaswamy K, Dudeja PK. The probiotic Lactobacillus plantarum counteracts TNF-α-induced downregulation of SMCT1 expression and function. Am J Physiol Gastrointest Liver Physiol. 2010; 299:G928–34.BorthakurAAnbazhaganANKumarARahejaGSinghVRamaswamyKDudejaPKThe probiotic Lactobacillus plantarum counteracts TNF-α-induced downregulation of SMCT1 expression and functionAm J Physiol Gastrointest Liver Physiol2010299G9283410.1152/ajpgi.00279.2010295733520671196Search in Google Scholar

[34]Kim H, Jung BJ, Jung JH, Kim JY, Chung SK, Chung DK. Lactobacillus plantarum lipoteichoic acid alleviates TNF-α-induced inflammation in the HT-29 intestinal epithelial cell line. Mol Cells. 2012; 33:479–86.KimHJungBJJungJHKimJYChungSKChungDKLactobacillus plantarum lipoteichoic acid alleviates TNF-α-induced inflammation in the HT-29 intestinal epithelial cell lineMol Cells2012334798610.1007/s10059-012-2266-5388772722526394Search in Google Scholar

[35]Puertollano E, Puertollano MA, Cruz-Chamorro L, Álvarez de Cienfuegos G, Ruiz-Bravo A, de Pablo MA. Orally administered Lactobacillus plantarum reduces pro-inflammatory interleukin secretion in sera from Listeria monocytogenes infected mice. Br J Nutr. 2008; 99:819–25.PuertollanoEPuertollanoMACruz-ChamorroLÁlvarezde Cienfuegos GRuiz-BravoAdePablo MAOrally administered Lactobacillus plantarum reduces pro-inflammatory interleukin secretion in sera from Listeria monocytogenes infected miceBr J Nutr2008998192510.1017/S000711450783253317894920Search in Google Scholar

[36]Panpetch W, Thiraworawong T, Tumwasorn S. Human gastric biopsy-derived lactobacilli suppress Helicobacter pylori-induced interleukin-8 production from gastric epithelial cells in vitro. Int J Infereron Cytokine Mediator Res. 2011; 3:43–9.PanpetchWThiraworawongTTumwasornSHuman gastric biopsy-derived lactobacilli suppress Helicobacter pylori-induced interleukin-8 production from gastric epithelial cells in vitroInt J Infereron Cytokine Mediator Res2011343910.2147/IJICMR.S19631Search in Google Scholar

[37]Dicks LM, ten Doeschate K. Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 alleviated symptoms of Salmonella infection, as determined in Wistar rats challenged with Salmonella enterica serovar Typhimurium. Curr Microbiol. 2010; 61:184–9.DicksLMtenDoeschate KEnterococcus mundtii ST4SA and Lactobacillus plantarum 423 alleviated symptoms of Salmonella infection, as determined in Wistar rats challenged with Salmonella enterica serovar TyphimuriumCurr Microbiol201061184910.1007/s00284-010-9594-520127245Search in Google Scholar